ARTICLE
Vol 133 No 1522: 25 September 2020

Why dizziness is likely to increase the risk of cognitive dysfunction and dementia in elderly adults

Dizziness is reported to be one of the most common reasons for patients consulting a general practitioner.

ARTICLE
Vol 133 No 1522: 25 September 2020

Knowledge and perspectives about the use of cannabis as a medicine: a mixed methods observational study in a cohort of New Zealand general practice patients

In December 2018 the New Zealand government introduced the Misuse of Drugs (Medicinal Cannabis) Amendment Act, allowing patients with a palliative diagnosis a statutory defence against the use of illicit cannabis in the management of their symptoms.

ARTICLE
Vol 133 No 1522: 25 September 2020

Medication dispensing for attention-deficit/hyperactivity disorder to New Zealand youth

Attention-deficit/hyperactivity disorder (ADHD) is a childhood-onset neurodevelopmental disorder characterised by symptoms of hyperactivity/impulsivity and inattention.

ARTICLE
Vol 133 No 1522: 25 September 2020

Lessons from a system-wide response to a measles outbreak, Canterbury, February–April 2019

Measles is a highly contagious airborne virus which affects both children and adults and can be life-threatening. Furthermore, measles infection can cause immune memory loss, increasing susceptibility to other infections for up to three years and contributing significantly to childhood non-measles infectious disease mortality.

ARTICLE
Vol 133 No 1522: 25 September 2020

Hui: a partnership in practice in familial hypercholesterolemia

Familial hypercholesterolemia (FH) is the most common dominant genetic disorder in humans and causes premature heart disease and death.

ARTICLE
Vol 133 No 1522: 25 September 2020

Are over-the-counter fish oil supplements safe, effective and accurate with labelling? Analysis of 10 New Zealand fish oil supplements

Fish oil supplements are among the most popular dietary supplements on the global market, with use having increased dramatically over the last decade.

ARTICLE
Vol 133 No 1522: 25 September 2020

A feasibility study investigating the impact of a dietitian-led low in fermentable oligosaccharide, disaccharide, monosaccharide and polyols diet group education programme with irritable bowel syndrome

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder (FGID) that affects 10–20% of the Western population.

ARTICLE
Vol 133 No 1522: 25 September 2020

Patient characteristics and predictors of completion of a pulmonary rehabilitation programme in Auckland, New Zealand

Chronic obstructive pulmonary disease (COPD) was the third leading cause of death in 2016 and resulted in more than three million deaths worldwide in 2015.2

ARTICLE
Vol 133 No 1522: 25 September 2020

How is dementia portrayed in New Zealand newsprint media? Causes, effects and moral evaluation

As the world’s population ages, dementia is increasingly recognised as a global public health priority. There are estimated to be approximately 50 million people worldwide currently living with dementia and this is projected to reach 150 million by 2050.

ARTICLE
Vol 133 No 1521: 4 September 2020

Inequalities between Māori and non-Māori men with prostate cancer in Aotearoa New Zealand

Prostate cancer is a major health concern globally. In 2015, prostate cancer was the most common incident of cancer in men, with an estimated 1.6 million cases worldwide, and fifth most common cause of cancer deaths for men, with an estimated 366,000 deaths worldwide.